跳至主要内容
临床试验/JPRN-UMIN000026645
JPRN-UMIN000026645已完成2 期

A Clinical Study to Evaluate the Efficacy and Safety of JR-031 in Patients with Epidermolysis Bullosa - A Clinical Study to Evaluate the Efficacy and Safety of JR-031 in Patients with Epidermolysis Bullosa

Osaka University0 个研究点目标入组 6 人开始时间: 2017年3月24日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
6

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
6years-old 至 70years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients who received a therapy with mesenchymal stem cell derived from human bone marrow or TEMUCELL HS injection. 2) Patients who are suffering from serious mental diseases. 3) Patients who are suffering from cancer or who have histories of suffering from cancer within 5 years prior to enrollment. 4) Patients who are pregnant or probably pregnant. 5) Patients who do not agree to take effective contraceptive measures during the study period. 6) Patients who have entered other clinical trials within 6 months prior to enrollment.

研究者

相似试验